Literature DB >> 15334285

The majority of hepatitis B carriers are not on regular surveillance in Singapore.

C T Wai1, B Mak, W Chua, S G Lim.   

Abstract

INTRODUCTION: Carriers of hepatitis B virus (HBV) are at risk of developing long-term complications. Regular surveillance helps detect treatable chronic hepatitis, cirrhosis and liver cancer, and is recommended by practice guidelines in the United States, Europe and Singapore. However, there have been few studies evaluating the follow-up of HBV carriers. This study seeks to determine the proportion of HBV carriers on regular follow-up in Singapore and the impact on hepatitis B disease.
METHODS: An advertisement was taken in local newspapers advertising for free screening to HBV carriers. 387 persons answered the advertisement. The screening comprised history-taking, physical examination, blood tests (liver panel, alphafoetoprotein, hepatitis B surface antigen (Ag) and hepatitis B eAg) and ultrasonography of liver. Further evaluation was conducted if the screening results were abnormal.
RESULTS: Of the 387 HBV carriers, 346 (89 percent) were male and 375 (97 percent) were Chinese. Their mean age was 39 years (range 20-60 years) and 36 percent were positive for HBeAg. 247 (64 percent) were not on regular screening over the past 12 months. 19 (5.4 percent) patients were diagnosed to have complications, namely: 13 had HBeAg-positive chronic hepatitis, two had HBeAg-negative chronic hepatitis, one had early liver cancer who recovered well after a curative resection and three had compensated cirrhosis.
CONCLUSION: Our screening programme diagnosed 5.4 percent of complications among 387 asymptomatic HBV carriers. However, 64 percent of the study subjects were not screened regularly and may pose an important public health threat if they develop long-term complications. Further studies are needed to evaluate and improve patient compliance for screening.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334285

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  7 in total

1.  Misperceptions among patients with chronic hepatitis B in Singapore.

Authors:  Chun-Tao Wai; Belinda Mak; Winnie Chua; Mei-Hua Tan; Seline Ng; Amelia Cheok; Mee-Lian Wong; Seng-Gee Lim
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

2.  Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.

Authors:  David Widjaja; Suresh Yarlagadda; Bheema S Singu; Raghu S Loganathan; Steve Blum; Alan Bloom; Prospere Remy
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

Review 3.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

4.  Chronic HBV carrier's acceptance of regular surveilling program in China.

Authors:  Qing Fang; You-Hua Hao; Lei Li; Zhen-Hua Zhang; Jun-Zhong Wang; Ming-Fa Chen; Jian Kang; Dong-Liang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

5.  Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?

Authors:  Huei-Ju Chen; Nicole Huang; Long-Sheng Chen; Yiing-Jenq Chou; Chung-Pin Li; Chen-Yi Wu; Yu-Chia Chang
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

6.  Hepatitis B Core Antigen in Hepatocytes of Chronic Hepatitis B: Comparison between Indirect Immunofluorescence and Immunoperoxidase Method.

Authors:  Ruksana Raihan; Shahina Tabassum; Mamun Al-Mahtab; Afzalun Nessa; Munira Jahan; Chowdhury Mohammad Shamim Kabir; Mohammad Kamal; Julio Cesar Aguilar
Journal:  Euroasian J Hepatogastroenterol       Date:  2015-01-06

Review 7.  Liver Disease in Singapore.

Authors:  Mark Muthiah; Chern H Chong; Seng G Lim
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.